DIVINE's table on antivirals received during hospitalization

Information on antivirals for patients included in the DIVINE cohort. Data was collected during hospitalization.

Usage

data(inhosp_antivirals)

Format

A data frame with 5813 rows and 10 columns

record_id:

Identifier of each record. This information does not match the real data.

covid_wave:

A factor with levels Wave 1, Wave 2, Wave 3, and Wave 5. COVID-19 wave.

center:

A factor with levels Hospital A, Hospital B, Hospital C, Hospital D, and Hospital E. Center of admission

any_antiviral:

A factor with levels No and Yes. Did the patient receive treatment with antivirals during hospital admission?

hydroxychloroquine:

A factor with levels No and Yes. Treatment with hydroxychloroquine

interferon_b:

A factor with levels No and Yes. Treatment with interferon beta

kaletra_ritonavir_lopinavir:

A factor with levels No and Yes. Treatment with kaletra/ritonavir-lopinavir

remdesivir:

A factor with levels No and Yes. Treatment with remdesivir

tocilizumab:

A factor with levels No and Yes. Treatment with tocilizumab

other_antiviral:

A factor with levels No and Yes. Treatment with another antiviral

References

Pallarès, N., Tebé, C., Abelenda-Alonso, G., Rombauts, A., Oriol, I., Simonetti, A. F., Rodríguez-Molinero, A., Izquierdo, E., Díaz-Brito, V., Molist, G., Gómez Melis, G., Carratalà, J., Videla, S., & MetroSud and Divine study groups (2023). Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study. Infectious diseases and therapy, 12(1), 273–289. https://doi.org/10.1007/s40121-022-00705-w